AI drug discovery firms insitro and Exscientia bag $200 million - Business Insider

日本 ニュース ニュース

AI drug discovery firms insitro and Exscientia bag $200 million - Business Insider
日本 最新ニュース,日本 見出し
  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

Pharma companies will likely eye tie ups with AI-focused startups as they race to develop treatments for the coronavirus

Business Insider Intelligenceinsitro uses its platform to analyze genetic and clinical data to discover new contenders for drug treatments — and it plans to put the fresh cash toward further developing its AI tech. The San Francisco-based biotech is different from most AI firms in that it produces its own vast amounts of data to train its machine learning technology, rather than leaning on existing data sets that could result in poorly trained platforms, Forbes.

Exscientia's platform uses AI to automate drug discovery and help design novel drug molecules — and it plans on expanding its pipeline and global footprint with its new funding. The UK-based firm facilitates drug discovery by applying its AI to published literature to identify drug targets. It entered its first drug — a treatment for OCD — into clinical trials last year and has landed partnerships with companies like Bristol-Myers Squibb, Bayer, and Scripps Research, for example.

We expect pharma companies to increasingly eye tie ups with AI-focused startups as they race to develop treatments for the coronavirus — but drug makers may not see a quick return on their investments. The coronavirus pandemic has sparked a great deal of

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

BusinessInsider /  🏆 729. in US

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Inside Facebook’s Bid to Crack the Fashion AI CodeInside Facebook’s Bid to Crack the Fashion AI CodeIf Facebook’s latest shopping announcements look impressive, get a load of what’s coming next.
続きを読む »

Exclusive: Machine Learning Company Insitro Raises $143 Million To Bridge Biology And AIExclusive: Machine Learning Company Insitro Raises $143 Million To Bridge Biology And AIThe company’s series B funding round was led by inventors at Andreessen Horowitz and includes new investor Casdin Capital. \n
続きを読む »

Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on Wednesday it had raised $105 million in funds.
続きを読む »

The Internet of Medical Things report - Business Insider - Business InsiderThe Internet of Medical Things report - Business Insider - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »

UK Parliament voices cash infrastructure concerns - Business Insider - Business InsiderUK Parliament voices cash infrastructure concerns - Business Insider - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »

Gatsby, Website-Building Startup Backed By Index Ventures, Raises $28 MillionGatsby, Website-Building Startup Backed By Index Ventures, Raises $28 MillionBerkeley-based Gatsby, which launched a platform last year to provide a suite of tools for website and app development, raised $28 million in a recent series B funding round
続きを読む »



Render Time: 2025-04-07 06:13:17